💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

IMF calls for $15 billion this year to manage long-term risks of COVID

Published 04/05/2022, 09:19 AM
Updated 04/05/2022, 09:27 AM
© Reuters. People wait to receive a dose of Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at a vaccination center as the Salvadoran government authorized a fourth dose of the vaccine in San Salvador, El Salvador, March 22, 2022. REUTERS/Jose Cabezas

WASHINGTON (Reuters) - Countries around the world should provide $15 billion in grants this year and $10 billion a year thereafter to manage the long-term risks of COVID-19, the International Monetary Fund said in a new staff paper released on Tuesday.

© Reuters. People wait to receive a dose of Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at a vaccination center as the Salvadoran government authorized a fourth dose of the vaccine in San Salvador, El Salvador, March 22, 2022. REUTERS/Jose Cabezas

The paper, prepared with the Coalition for Epidemic Preparedness Innovations (CEPI), the Global Fund, and charitable group Wellcome, said a new, more comprehensive approach was needed immediately to strengthen global health systems and limit the already staggering $13.8 trillion cost of the pandemic.

"The cost of inaction – for all of us – is very high. We need to act – now," IMF First Deputy Managing Director Gita Gopinath said in a statement.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.